ArticleThe Journal of antimicrobial chemotherapy2022

In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination.

Andrew J Fratoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.